Peripheral Vascular Disease [clinicaltrials_resource:3325f872c477250441cf2da448aa5c62]
Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty [clinicaltrials:NCT00004549]Extract of Ginkgo Biloba (EGB 761) and Vascular Function [clinicaltrials:NCT00029991]Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease [clinicaltrials:NCT00053716]Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease [clinicaltrials:NCT00059644]Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease [clinicaltrials:NCT00059657]Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia [clinicaltrials:NCT00060892]Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures [clinicaltrials:NCT00060996]Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication [clinicaltrials:NCT00062556]Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft [clinicaltrials:NCT00067041]Trial of VLTS-589 in Subjects With Intermittent Claudication [clinicaltrials:NCT00068133]The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC [clinicaltrials:NCT00071266]Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication [clinicaltrials:NCT00102050]Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease [clinicaltrials:NCT00113009]clinicaltrials:NCT00117650Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures [clinicaltrials:NCT00154141]Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries [clinicaltrials:NCT00185276]clinicaltrials:NCT00189540Oslo Balloon Angioplasty Versus Conservative Treatment [clinicaltrials:NCT00222196]FIRE-PAD: Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial Disease [clinicaltrials:NCT00274157]Stem Cell Injection for Peripheral Vascular Disease [clinicaltrials:NCT00278603]Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia [clinicaltrials:NCT00300040]clinicaltrials:NCT00328094Testosterone Replacement in Diabetes With Vascular Disease (Version 2) [clinicaltrials:NCT00355537]Systematic Assessment of Vascular Risk [clinicaltrials:NCT00378040]RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease [clinicaltrials:NCT00385385]clinicaltrials:NCT00392509Crossover Study With MultiHance vs a Comparator for Peripheral MRA [clinicaltrials:NCT00408083]Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease [clinicaltrials:NCT00431249]clinicaltrials:NCT00434616Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial [clinicaltrials:NCT00437905]clinicaltrials:NCT00439309Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets [clinicaltrials:NCT00442325]Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) [clinicaltrials:NCT00442845]The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes [clinicaltrials:NCT00456105]clinicaltrials:NCT00471289A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System [clinicaltrials:NCT00475566]Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions [clinicaltrials:NCT00481741]Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification [clinicaltrials:NCT00496041]Testosterone for Peripheral Vascular Disease [clinicaltrials:NCT00504712]Drug Eluting Stents In The Critically Ischemic Lower Leg [clinicaltrials:NCT00510393]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Peripheral Vascular Disease [clinicaltrials_resource:3325f872c477250441cf2da448aa5c62]
Bio2RDF identifier
3325f872c477250441cf2da448aa5c62
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3325f872c477250441cf2da448aa5c62
identifier
clinicaltrials_resource:3325f872c477250441cf2da448aa5c62
title
Peripheral Vascular Disease
@en
label
Peripheral Vascular Disease [clinicaltrials_resource:3325f872c477250441cf2da448aa5c62]
@en